BARCELONA, Spain, Nov. 4, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest albumin ...
Albumin human is derived from human plasma, used to treat shock as a result of blood loss in the body (hypovolemia), burns, low protein levels (hypoproteinemia) due to surgery or liver failure, adult ...
FDA Approves Baxter’s FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International, Inc. (NYSE:BAX) today announced that the United States Food and Drug Administration (FDA) has approved FLEXBUMIN ® [Albumin (Human)], USP, 5% ...
BARCELONA, Spain, July 18, 2023 (GLOBE NEWSWIRE) -- Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), one of the world’s leading producers of plasma-derived medicines, today announced it has completed ...
Albumin Human (Sll Human Albumin) is derived from human plasma, used to treat shock as a result of blood loss in the body (hypovolemia), burns, low protein levels (hypoproteinemia) due to surgery or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results